Kopchick elected president of Growth Hormone Research
(ATHENS, Ohio – Feb. 4, 2013) John Kopchick, Ph.D., Goll-Ohio
Eminent Scholar and professor of molecular biology at Ohio
University, was elected president of the Growth Hormone Research
Society (GRS). He is the first basic scientist to assume the role.
GRS is a forum for the study and exchange of ideas on all aspects of
growth hormone physiology, and diseases involving abnormalities of
the GH axis.
As president, Dr. Kopchick will oversee the GRS biannual meeting,
which brings together more than 400 clinicians, scientists and
educators from 30 countries with their sister organization, the
International Society for Insulin-Like Growth Factors (IGF) Society,
to examine issues related to growth hormone action in humans and
animals. Together, the two societies also publish The Journal of
GH and IGF research.
“To be nominated and elected as president for a group of
international clinicians and scientists all in the growth hormone
area is certainly a wonderful and humbling honor,” said Dr. Kopchick.
“I cannot explain how happy and excited I am about this new
The independent, non-profit society also sponsors regular workshops,
in which participants issue a consensus report that is published in
well-respected endocrine journals. Their next workshop, held in fall
of 2013, will address the safety of recombinant human growth hormone
“This is currently a very ‘hot’ topic,” Dr. Kopchick said. “The
participants in the workshop, all experts in the GH field, will go
over the published data related to the topic and then generate a
consensus statement that will be published. In this case,
clinicians will review the subject matter of the consensus report
and may modify their interaction with their patients who
are receiving GH therapy.”
internationally for his 1989 discovery
of a compound that became the basis for a drug, Somavert®, that
treats acromegaly, a disorder that can cause excessive growth of
organs and bones and can lead to premature death. The treatment has
improved thousands of lives and has earned substantial royalties
that support Ohio University research programs.
In addition, Dr. Kopchick has received numerous national and
international awards, has published more than 290 scientific
articles, and has been involved in three start-up companies. In
January, 2012, OU-HCOM created an endowed research chair, the John
J. Kopchick, Ph.D., Osteopathic Heritage Foundation Endowed Eminent
Research Chair, to recognize the world-renowned endocrinologist and
his contributions to the college, the university and the medical
The Seventh International Congress of the GRS and IGF Society will
be held from Oct. 15-18, 2014, in Singapore.